AbbVie · 19 hours ago
Director, HEOR Strategy, US Access Evidence Strategy and Execution
Mettawa, IL
Full-time
Onsite
Mid, Senior Level
5+ years expAbbVie is a company dedicated to discovering and delivering innovative medicines that address serious health issues. The Director of HEOR Strategy will be responsible for developing and executing strategies related to drug price negotiation programs and ensuring effective communication of findings to various stakeholders.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
In coordination with IRA Navigation and Possibilities (NAP) Leads, Government Affairs, other Neuroscience leads, HEOR Neuroscience leadership, evaluate neuroscience evidence strategies
Educate and embed IRA operational readiness into Neuroscience HEOR team to accelerate and optimize IRA engagement outcomes
Provide thought leadership to neuroscience R&D, MHI, and PCS leadership and coordination with Government Affairs to ensure a deep and discreet organizational understanding of IRA impacts to neuroscience access evidence strategy
Oversees the design and conduct, of projects and effectively communicates the findings and strategic impact of findings to internal and external audiences
Ensures project plan integrates and aligns with neuroscience access strategic plans from matrix teams as well as commercial interests. Provides updates on execution of plans, owns, then shares project execution decisions
Accountable for end-to-end delivery of HEOR book of work under their remit, from strategy development to content pull through
Accountable to ensuring strong partnership with all relevant HEOR COE functions to ensure a comprehensive HEOR voice is represented in cross-functional meetings
Executive presence and ability to engage with senior leaders in a cross functional setting
Qualification
Required
Advanced degree in health economics or related discipline
Minimum of seven years working experience with Master's, five year with PhD (can include fellowship experience). Professional training and experience in the US private and/or public payer setting is strongly preferred
Proven leadership skills in a cross-functional global team environment. Ability to interact externally and internally to support global business strategy
The Director must perform at times in previously uncharted territory with few, if any, established guidelines or procedures. At other times, exceedingly complex governmental rules and regulations must be followed. For problems surrounded by complex rules and regulations, the Director must be able to direct compliance knowledgeably and expeditiously
Must be able to develop creative and effective solutions to inter- and intra-project priority conflicts, resource constraints and other problems which may impact project or group goals and deliverables across multiple programs
High goal-orientation with the ability to see solutions rather than problems as projects encounter the inevitable ups and downs associated with new drug development or on-market product support
Extensive knowledge of the global regulatory, HTA and PR&A landscape, as well as understanding of other development-related functions as they relate to all phases of drug development
Skills to perform the dual roles of leading a cross functional team and managing scientific personnel in clinical research. Must be able to interact successfully with Senior Management globally (Executive staff, Area VPs, GMs etc.) and act as the HEOR project/group champion and spokesperson. Additionally, must be a self-starter and have a strong desire to see projects achieve commercial success globally (Executive staff, Area VPs, GMs etc.) and act as the HEOR project/group champion and spokesperson. Additionally, must be a self-starter and have a strong desire to see projects achieve commercial success
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Short-term incentive programs
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Robert Michael
Chairman of the Board and Chief Executive Officer
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
Recent News
2026-01-23
2026-01-20
2026-01-20
Company data provided by crunchbase